Shares of Inhibikase Therapeutics rose as much as 18% on Wednesday, but finished the day 10c below the stock's $10 IPO price. Inhibikase was scheduled to trade last month but delayed the deal.
LATEST IPOS:
Inhibikase Therapeutics (IKT) opened on December 23 at $10.67. The company had priced 1.36M shares at $10.00. The deal size was increased to 1.8M shares from 1.36M shares and the range was $10.00-$12.00. ThinkEquity acted as sole book running manager for the offering. Inhibikase uses small-molecule oral protein kinase inhibitors to treat Parkinson’s disease and the gastrointestinal issues that arise in early stages of the disease.
SPAC IPOS:
CF Acquisition Corp. IV (CFIV) opened on December 23 at $10.25. The blank check company had priced its upsized initial public offering of 45M units at $10.00 per unit. CF Acquisition Corp. IV intends to focus on industries "where its management team and founders have experience, including the financial services, healthcare, real estate services, technology and software industries."
7GC & Co. Holdings (VIIA) opened on December 23 at $10.34. The blank check company had priced its upsized initial public offering of 20M units at $10.00 per unit. While 7GC & Co. Holdings may pursue an initial business combination target in any industry or sector, it intends to concentrate its efforts in identifying businesses in the technology industry.
Viveon Health Acquisition (VHAQ) opened on Decmber 23 at $10.40. The blank check company had priced its initial public offering of 17.5M units at $10.00 per unit.
Ackrell SPAC Partners I Co. (ACKIT) opened on December 21 at $10.09. The blank check company had priced its upsized initial public offering of 12M units at $10.00 per unit. Ackrell intends to concentrate its efforts on identifying businesses in the "branded fast-moving consumer goods industry."
PERFORMANCE:
UPCOMING IPOS: Among the upcoming IPOs are Coinbase (COIN), Caliber Home Loans (HOMS) and Pharming Group (PHAR).
Coinbase Global has announced via a post to its corporate blog that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission. "The Form S-1 is expected to become effective after the SEC completes its review process, subject to market and other conditions," Coinbase stated. Coinbase is the largest U.S. cryptocurrency exchange.
New Residential Investment (NRZ) has announced that an affiliate of NewRez, a mortgage lending and servicing organization, has confidentially submitted a draft registration statement with the SEC relating to the proposed initial public offering of NewRez's common stock. The initial public offering is expected to take place after the SEC completes its review process.
Caliber Home Loans is a financial services company and an approved Seller/Servicer for both Fannie Mae and Freddie Mac, an approved issuer for Ginnie Mae and is an approved servicer for FHA, VA and the USDA.
Pharming Group is a commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.
"Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, analyst commentary and upcoming IPOs.
Inhibikase Therapeutics
-0.53 (-5.28%)
CF Acquisition Corp. IV
+ (+0.00%)
7GC & Co. Holdings
+ (+0.00%)
Viveon Health Acquisition
+ (+0.00%)
Ackrell SPAC Partners I Co.
+ (+0.00%)
Coinbase
+ (+0.00%)
Caliber Home Loans
+ (+0.00%)
Pharming
-1.03 (-6.20%)
New Residential
-0.135 (-1.32%)